Login
Register
Submit a Paper
Propose a Special lssue
Open Access
ARTICLE
PSA implications and medical management of prostate cancer for the primary care physician
Department of Surgery, McMaster University, Hamilton, Ontario, Canada
Address correspondence to Dr. Bobby Shayegan, St. Joseph’s
Healthcare Hamilton, 3rd Floor Mary Grace Wing, 50 Charlton
Avenue East, Hamilton, Ontario L8N 4A6 Canada
Canadian Journal of Urology 2012, 19(Suppl.5), 28-35.
Download PDFAbstract
Prostate cancer remains a common cancer diagnosis and cause of cancer-related death in men. Despite it’s high prevalence, screening for prostate cancer for early detection remains controversial. This article outlines evidence from contemporary prostate cancer screening clinical trials and presents an overview of therapeutic options across the spectrum of prostate-cancer states.Keywords
prostate adenocarcinoma, prostate cancer, prostate cancer screening, prostate-specific antigen (PSA)
Cite This Article
APA Style
Rehsia, S., Shayegan, B. (2012). PSA implications and medical management of prostate cancer for the primary care physician. Canadian Journal of Urology, 19(Suppl.5), 28–35.
Vancouver Style
Rehsia S, Shayegan B. PSA implications and medical management of prostate cancer for the primary care physician. Can J Urology. 2012;19(Suppl.5):28–35.
IEEE Style
S. Rehsia and B. Shayegan, “PSA implications and medical management of prostate cancer for the primary care physician,” Can. J. Urology, vol. 19, no. Suppl.5, pp. 28–35, 2012.
Copyright © 2012 The Author(s). Published by Tech Science Press.This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Downloads
Citation Tools
